Form Type: 4/A

SEC EDGAR Link
Accession Number:0001628280-21-017225
Date:2021-08-16
Issuer: BELLICUM PHARMACEUTICALS, INC (BLCM)
Original Submission Date:2021-08-16

Reporting Person:

FAIR RICHARD A.
C/O BELLICUM PHARMACEUTICALS, INC.
3730 KIRBY DRIVE, SUITE 1200 HOUSTON, TX 77098

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.88 2021-08-16 deemed execution date A 265,000 (a) 2022-08-16 2031-08-16 common stock 265,000 $2.88 265,000 direct
Footnotes
IDfootnote
f1 this amendment is being filed to correct the typographical error in the exercise price of the stock option on the original form 4 filed with the sec on august 16, 2021
WhaleWisdom Logo

Elevate your investments